Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated

Medications: What Works and What Doesn't

At a Glance

Nociplastic pain often responds poorly to standard painkillers because it involves altered pain processing in the central nervous system. Medicines such as duloxetine, milnacipran, pregabalin, or low-dose amitriptyline may offer modest support, while opioids are generally not recommended.

When it comes to nociplastic pain, the medicine cabinet looks very different than it does for a broken bone or a post-surgery recovery. Because the issue is “central”—meaning it involves the brain and spinal cord—standard painkillers often miss the mark. Understanding which medications work, and why others don’t, can help you avoid unnecessary side effects and focus on therapies that support your function [1][2].

Standard Painkillers and Their Limits

Many people start their journey by taking common over-the-counter medications. However, for nociplastic pain, these often provide limited relief and carry serious risks:

  • NSAIDs (like Ibuprofen or Naproxen): These drugs are designed to reduce inflammation and tissue damage at the site of an injury [3]. While they may help coexisting inflammatory pain (like arthritis), they are generally ineffective for the central nociplastic mechanism. Safety Warning: Long-term NSAID use carries major risks of gastrointestinal bleeding, kidney injury, and cardiovascular problems. Do not stop prescribed medicines without advice, but discuss their utility with your doctor [4][3].
  • Acetaminophen (Tylenol): While safer for the stomach, acetaminophen has not been shown to be highly effective for central amplification in conditions like fibromyalgia [5][6]. Safety Warning: It can cause severe liver injury if the maximum daily dose is exceeded or if combination products are duplicated.

The Concern with Opioids

It may seem logical to reach for the strongest possible painkiller for intense pain, but opioids (like oxycodone or hydrocodone) are generally not recommended for nociplastic-predominant pain [7][8].

  • Limited Benefit, Substantial Harm: Opioids offer limited benefit for central sensitization and carry high risks of sedation, respiratory depression, and dependence [1].
  • Opioid-Induced Hyperalgesia (OIH): Long-term opioid use can sometimes make your nervous system more sensitive to pain, though this is difficult to distinguish from tolerance, withdrawal, or disease progression [9][10].
  • Observational Outcomes: Studies associate long-term opioid use in these conditions with worse functional outcomes, though they do not prove opioids caused the decline [11][12].
  • Safety Warning: If you are already taking opioids, never stop abruptly. Discuss a gradual, individualized taper with your prescriber.

Centrally Acting Medications

Instead of targeting the “periphery” (the site where it hurts), doctors use medications that work on the central nervous system. Evidence for these drugs differs by condition, dose, and country [7][13].

Drug Class Common Examples Important Safety & Use Notes
SNRIs Duloxetine (Cymbalta), Milnacipran (Savella) Helps modulate pain signals. Can cause nausea, dizziness, and requires a slow taper if stopped [14].
Gabapentinoids Pregabalin (Lyrica), Gabapentin (Neurontin) Calms overactive nerve cells. Pregabalin has more specific fibromyalgia evidence than gabapentin. Risks: Sedation, dizziness, falls, and requires attention to kidney function [15][16].
Tricyclic Antidepressants Amitriptyline (Elavil) Used in low doses to improve sleep and pain signaling. Risks: Dry mouth, constipation, sedation, and anticholinergic or cardiac effects (especially in older adults) [17].

Managing Your Expectations

It is important to be honest about what these medications can achieve. For most patients, average benefit is modest and varies substantially between people:

  • Side Effects: Many people experience side effects like dizziness, dry mouth, or sleepiness, which often limit use [18][19].
  • The “Support” Role: Think of these medications as a “buffer.” Their job is to lower the pain enough so that you can participate in more effective treatments, like improved sleep and graded activity [20][21].
  • Safety First: Do not start, stop, combine, or change doses without a clinician or pharmacist’s explicit advice [2].

Common questions in this guide

Which medications are commonly considered for nociplastic pain?
Doctors may consider centrally acting medicines such as duloxetine or milnacipran, pregabalin or gabapentin, and low-dose amitriptyline. The best choice depends on the condition, symptoms, other medicines, kidney or heart health, and side-effect risks. Benefits are often modest and vary from person to person.
Can ibuprofen, naproxen, or acetaminophen relieve nociplastic pain?
These common pain relievers often provide limited relief when pain is mainly nociplastic because they do not target altered pain processing. NSAIDs may still help a separate inflammatory problem, such as arthritis, but long-term use can cause stomach bleeding, kidney injury, or cardiovascular problems. Acetaminophen can cause serious liver injury if the daily dose is exceeded or combination products are duplicated.
Why are opioids usually avoided for nociplastic pain?
Opioids generally offer limited benefit for nociplastic-predominant pain while increasing the risk of sedation, slowed breathing, and dependence. Long-term use can also make the nervous system more sensitive to pain in some people, although this can be hard to distinguish from tolerance or withdrawal. Anyone taking opioids should discuss a gradual, individualized taper and never stop suddenly.
What side effects should I watch for with centrally acting pain medicines?
Possible effects include nausea, dizziness, sleepiness, dry mouth, constipation, and falls. Some medicines require attention to kidney function, heart risks, or sedation, especially in older adults. Your clinician or pharmacist can explain which warning signs apply to your medication.
What should be the goal of medication treatment for nociplastic pain?
Medication is often used as support, not as a cure or a way to eliminate every pain signal. The goal may be to reduce pain enough to improve sleep, movement, or participation in graded activity and other treatments. Agree with your clinician on how long to try a medicine and what benefit would justify continuing it.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my specific symptoms—like my sleep issues or fatigue—which medication class would you suggest considering?
  2. 2.What is our 'exit strategy' if a medication doesn't show a clear benefit within a certain timeframe?
  3. 3.Are there specific side effects, like dizziness, sedation, or heart risks, that I should watch for?
  4. 4.Can we review how this medication will support my functional goals rather than just lowering my pain score?
  5. 5.If I'm currently taking an opioid, can we discuss a safe, slow tapering plan?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Nociplastic pain: towards an understanding of prevalent pain conditions.

    Fitzcharles MA, Cohen SP, Clauw DJ, et al.

    Lancet (London, England) 2021; (397(10289)):2098-2110 doi:10.1016/S0140-6736(21)00392-5.

    PMID: 34062144
  2. 2

    From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?

    Clauw DJ

    Annals of the rheumatic diseases 2024; (83(11)):1421-1427 doi:10.1136/ard-2023-225327.

    PMID: 39107083
  3. 3

    Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis.

    Machado GC, Maher CG, Ferreira PH, et al.

    Annals of the rheumatic diseases 2017; (76(7)):1269-1278 doi:10.1136/annrheumdis-2016-210597.

    PMID: 28153830
  4. 4

    Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics.

    Moore N, Scheiman JM

    Postgraduate medicine 2018; (130(2)):188-199 doi:10.1080/00325481.2018.1429793.

    PMID: 29417856
  5. 5

    Oral paracetamol (acetaminophen) for cancer pain.

    Wiffen PJ, Derry S, Moore RA, et al.

    The Cochrane database of systematic reviews 2017; (7()):CD012637 doi:10.1002/14651858.CD012637.pub2.

    PMID: 28700092
  6. 6

    Acetaminophen or Nonsteroidal Anti-Inflammatory Drugs in Acute Musculoskeletal Trauma: A Multicenter, Double-Blind, Randomized, Clinical Trial.

    Ridderikhof ML, Lirk P, Goddijn H, et al.

    Annals of emergency medicine 2018; (71(3)):357-368.e8 doi:10.1016/j.annemergmed.2017.08.041.

    PMID: 29033294
  7. 7

    The concept of nociplastic pain-where to from here?

    Kosek E

    Pain 2024; (165(11S)):S50-S57 doi:10.1097/j.pain.0000000000003305.

    PMID: 39560415
  8. 8

    Opioid Use in Fibromyalgia: A Cautionary Tale.

    Goldenberg DL, Clauw DJ, Palmer RE, Clair AG

    Mayo Clinic proceedings 2016; (91(5)):640-8.

    PMID: 26975749
  9. 9

    Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain.

    Matsuda M, Huh Y, Ji RR

    Journal of anesthesia 2019; (33(1)):131-139 doi:10.1007/s00540-018-2579-4.

    PMID: 30448975
  10. 10

    Central sensitization in opioid use disorder: a novel application of the American College of Rheumatology Fibromyalgia Survey Criteria.

    Hall OT, Teater J, Rood KM, et al.

    Pain reports 2022; (7(4)):e1016 doi:10.1097/PR9.0000000000001016.

    PMID: 35812839
  11. 11

    Association Between Nociplastic Pain and Pain Severity and Impact in Women With Chronic Pelvic Pain.

    Till SR, Schrepf A, Clauw DJ, et al.

    The journal of pain 2023; (24(8)):1406-1414 doi:10.1016/j.jpain.2023.03.004.

    PMID: 36958459
  12. 12

    Nociplastic Pain and Central Sensitization in Hip and Knee Arthroplasty: A Practical Primer for Arthroplasty Surgeons.

    Carender CN, Kheir MM, Dailey EA, Clauw DJ

    Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews 2026; (10(3)) doi:e25.00471.

    PMID: 41779934
  13. 13

    How to treat chronic pain in rheumatic and musculoskeletal diseases (RMDs) - A pharmacological review.

    Gérard B, Bailly F, Trouvin AP

    Joint bone spine 2024; (91(1)):105624 doi:10.1016/j.jbspin.2023.105624.

    PMID: 37495074
  14. 14

    Efficacy of antidepressants in the treatment of chronic nonspecific low back pain: a systematic review and meta-analysis.

    Leão Nunes Filho MJ, Barreto ESR, Antunes Júnior CR, et al.

    Pain management 2024; (14(8)):437-451 doi:10.1080/17581869.2024.2408215.

    PMID: 39377458
  15. 15

    Pregabalin for pain in fibromyalgia in adults.

    Derry S, Cording M, Wiffen PJ, et al.

    The Cochrane database of systematic reviews 2016; (9()):CD011790 doi:10.1002/14651858.CD011790.pub2.

    PMID: 27684492
  16. 16

    Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

    Finnerup NB, Attal N, Haroutounian S, et al.

    The Lancet. Neurology 2015; (14(2)):162-73.

    PMID: 25575710
  17. 17

    Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.

    Farag HM, Yunusa I, Goswami H, et al.

    JAMA network open 2022; (5(5)):e2212939 doi:10.1001/jamanetworkopen.2022.12939.

    PMID: 35587348
  18. 18

    Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.

    Welsch P, Üçeyler N, Klose P, et al.

    The Cochrane database of systematic reviews 2018; (2()):CD010292 doi:10.1002/14651858.CD010292.pub2.

    PMID: 29489029
  19. 19

    Adverse Effects of Antidepressants for Chronic Pain: A Systematic Review and Meta-analysis.

    Riediger C, Schuster T, Barlinn K, et al.

    Frontiers in neurology 2017; (8()):307 doi:10.3389/fneur.2017.00307.

    PMID: 28769859
  20. 20

    Functional pain disorders - more than nociplastic pain.

    Popkirov S, Enax-Krumova EK, Mainka T, et al.

    NeuroRehabilitation 2020; (47(3)):343-353 doi:10.3233/NRE-208007.

    PMID: 32986624
  21. 21

    Evidence-Based Self-Management Strategies for Fibromyalgia: Foundations for Digital Therapeutic Applications.

    Lebeau Foustoukos T, Leclercq I, Blanchard M, Hügle T

    Interactive journal of medical research 2026; (15()):e67523 doi:10.2196/67523.

    PMID: 41701966

This page is for informational purposes only and does not constitute medical advice. Ask your clinician or pharmacist before starting, stopping, combining, or changing any medication for nociplastic pain.

Get notified when new evidence is published on Nociplastic Pain.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.